SAFETY AND PHARMACOKINETIC PROFILE OF ASCENDING SINGLE DOSES OF ORAL LIQUID SIROLIMUS (Rapamycin) IN PEDIATRIC PATIENTS WITH STABLE CHRONIC RENAL FAILURE.

Abstract
No abstract available

This publication has 0 references indexed in Scilit: